Our previous work has shown that SOX2 elevation in five cell lines representing three tumor types (prostate, pancreatic, and medulloblastoma) does not significantly perturb the cell cycle distribution of engineered cells despite inhibiting growth [22]. Here, SOX2 is linked to medulloblastoma.